Issue 26, 2013

Picomolar inhibition of cholera toxin by a pentavalent ganglioside GM1os-calix[5]arene

Abstract

Cholera toxin (CT), the causative agent of cholera, displays a pentavalent binding domain that targets the oligosaccharide of ganglioside GM1 (GM1os) on the periphery of human abdominal epithelial cells. Here, we report the first GM1os-based CT inhibitor that matches the valency of the CT binding domain (CTB). This pentavalent inhibitor contains five GM1os moieties linked to a calix[5]arene scaffold. When evaluated by an inhibition assay, it achieved a picomolar inhibition potency (IC50 = 450 pM) for CTB. This represents a significant multivalency effect, with a relative inhibitory potency of 100 000 compared to a monovalent GM1os derivative, making GM1os-calix[5]arene one of the most potent known CTB inhibitors.

Graphical abstract: Picomolar inhibition of cholera toxin by a pentavalent ganglioside GM1os-calix[5]arene

Supplementary files

Article information

Article type
Paper
Submitted
13 Mar 2013
Accepted
29 Apr 2013
First published
20 May 2013
This article is Open Access
Creative Commons BY license

Org. Biomol. Chem., 2013,11, 4340-4349

Picomolar inhibition of cholera toxin by a pentavalent ganglioside GM1os-calix[5]arene

J. Garcia-Hartjes, S. Bernardi, C. A. G. M. Weijers, T. Wennekes, M. Gilbert, F. Sansone, A. Casnati and H. Zuilhof, Org. Biomol. Chem., 2013, 11, 4340 DOI: 10.1039/C3OB40515J

This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. You can use material from this article in other publications without requesting further permissions from the RSC, provided that the correct acknowledgement is given.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements